2 news items
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
IVVD
22 Mar 24
antibodies after vaccination or monoclonal antibody administration." Nature communications vol. 14,1 3605. 17 Jun. 2023
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
IVVD
22 Mar 24
from COVID-19." Nature communications vol. 14,1 4545. 28 Jul. 2023, doi:10.1038/s41467-023-40204-1. Cautionary Note Regarding
- Prev
- 1
- Next